Joseph Romanelli - 30 Apr 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: President, Human Health Int?l
Signature: /s/ Kelly E. W. Grez, attorney-in-fact for Joseph Romanelli
Issuer symbol: MRK
Transactions as of: 30 Apr 2024
Net transactions value: +$147,734
Form type: 4
Filing time: 02 May 2024, 16:29:38 UTC
Previous filing: 14 Feb 2024
Next filing: 14 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRK	Common Stock	Options Exercise	$291,346	+2,262	+12%	$128.80	21,831	02 May 2024	Direct
transaction	MRK	Common Stock	Tax liability	$143,612	-1,115	-5.1%	$128.80	20,716	02 May 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Restricted Stock Unit	Award	$0	+6,191		$0.000000	6,191	30 Apr 2024	Common Stock	6,191		Direct	F1, F2
transaction	MRK	Stock Option (Right to Buy)	Award	$0	+23,438		$0.000000	23,438	30 Apr 2024	Common Stock	23,438	$129.22	Direct	F3
transaction	MRK	Restricted Stock Unit	Options Exercise	$0	-2,262	-33%	$0.000000	4,524	02 May 2024	Common Stock	2,262		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
F3	The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
F4	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.